Health-related quality of life impact of a triple combination of olmesartan medoxomil, amlodipine besylate and hydrochlorotiazide in subjects with hypertension
Crossref DOI link: https://doi.org/10.1186/s12955-015-0216-6
Published Online: 2015-02-21
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Marques da Silva, Pedro
Haag, Uwe
Guest, Julian F
Brazier, John E
Soro, Marco
License valid from 2015-02-21
Article History
Received: 1 September 2014
Accepted: 27 January 2015
First Online: 21 February 2015